136 related articles for article (PubMed ID: 38581118)
1. Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation.
Pershad AR; Thakkar PG; Goodman JF; Joshi A; Steinberg SM; Allen CT; Floudas CS
Cancer Med; 2024 Apr; 13(7):e7146. PubMed ID: 38581118
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
3. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
4. Swallowing Function Following Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Carcinoma: A 2-Year Follow-up.
Lee E; Gorelik D; Crowder HR; Badger C; Schottler J; Li NW; Siegel R; Sadeghi N; Goodman JF; Thakkar PG; Joshi AS
Otolaryngol Head Neck Surg; 2022 Aug; 167(2):298-304. PubMed ID: 34752157
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
6. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
[TBL] [Abstract][Full Text] [Related]
7. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
[TBL] [Abstract][Full Text] [Related]
9. Neo-adjuvant chemotherapy and transoral robotic surgery in locoregionally advanced oropharyngeal cancer.
Costantino A; Sampieri C; De Virgilio A; Kim SH
Eur J Surg Oncol; 2023 Dec; 49(12):107121. PubMed ID: 37879162
[TBL] [Abstract][Full Text] [Related]
10. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
13. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status.
Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265
[TBL] [Abstract][Full Text] [Related]
14. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
[TBL] [Abstract][Full Text] [Related]
16. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.
Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM
Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133
[TBL] [Abstract][Full Text] [Related]
17. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
Weiss JM; Grilley-Olson JE; Deal AM; Zevallos JP; Chera BS; Paul J; Knowles MF; Usenko D; Weissler MC; Patel S; Hayes DN; Hackman T
Cancer; 2018 Jul; 124(14):2986-2992. PubMed ID: 29741773
[TBL] [Abstract][Full Text] [Related]
19. Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.
Jackson RS; Sinha P; Zenga J; Kallogjeri D; Suko J; Martin E; Moore EJ; Haughey BH
Ann Surg Oncol; 2017 Nov; 24(12):3494-3501. PubMed ID: 28808988
[TBL] [Abstract][Full Text] [Related]
20. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
